YOLFTbeta
68

Shandong Weigao Orthopaedic Device Co. Ltd. A

688161 · SHG · Healthcare / Medical Devices

20.09CNY-0.43 (-2.10%)

Price History

Full chart

Market Stats

Previous Close20.52
Open20.79
Day Range20.07 – 20.81
52-Week Range19.83 – 33.17
Volume863.86K
Market Cap8.72B
P/E (TTM)33.52
Forward P/E0.00
EPS0.65
Dividend Yield1.51%
Beta0.17
50-Day Avg21.78
200-Day Avg26.24

About

Shandong Weigao Orthopaedic Device Co., Ltd. engages in research, development, production, and sales of orthopedic medical devices. The company offers orthopedic implantable medical devices and orthopedic surgical instruments. It also provides spinal products, such as internal fixation systems for the cervical and thoracic/lumbar spine, and interbody fusion devices; trauma-related products include locking plate systems, intramedullary nail systems, hollow screw systems, and external fixation systems; and joint products, including hip joint prosthesis systems, knee joint prosthesis systems, and shoulder joint prosthesis systems. In addition, the company sports medicine products comprise cruciate ligament reconstruction system, meniscus repair system, and sports trauma system; craniofacial surgery products; and orthopedic diagnostic equipment. The company was founded in 2005 and is based in Weihai, China. Shandong Weigao Orthopaedic Device Co., Ltd. operates as a subsidiary of Shandong Weigao Group Medical Polymer Co., Limited.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. NA NA
  • Employees2.02K
  • HeadquartersNo. 26, Xiangjiang Street, Weihai, China, 264200, China
  • Websitehttps://www.wegortho.com

Leadership

  • Mr. NA NAGeneral manager & Director · b. 1987
  • Ms. Yun Lu SuCFO Accounting Supervisor & Director · b. 1971
  • Mr. Jian Ming KongDeputy GM & Director · b. 1970
  • Ms. Qing LinBoard Secretary · b. 1980

Financials

Income Statement

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.57B1.82B2.15B2.06B1.28B1.45B1.52B
Growth (%)-+15.87%+18.08%-4.44%-37.63%+13.18%+4.82%
Cost of Revenue275.19M321.73M405.42M482.05M429.70M497.84M534.83M
Gross Profit1.30B1.50B1.75B1.58B853.85M954.88M987.96M
Gross Margin82.52%82.36%81.17%76.58%66.52%65.73%64.88%
Operating Expense781.89M824.65M964.45M919.38M762.08M699.79M666.87M
Operating Income516.93M677.40M783.68M656.55M91.77M255.09M321.10M
Operating Margin32.84%37.14%36.39%31.90%7.15%17.56%21.09%
EBITDA557.49M719.05M862.02M763.73M194.97M336.82M392.00M
EBITDA Margin35.42%39.43%40.03%37.11%15.19%23.19%25.74%
Net Income441.67M558.40M690.32M600.70M112.32M223.75M268.64M
Net Income Margin28.06%30.62%32.05%29.19%8.75%15.40%17.64%
R&D74.09M82.46M121.23M117.66M130.20M119.90M112.30M
R&D as % of Total Revenue4.71%4.52%5.63%5.72%10.14%8.25%7.37%
Interest Expense13.74M12.62M610.75K613.12K945.77K1.04M975.39K
Interest Expense % of Total Revenue0.87%0.69%0.03%0.03%0.07%0.07%0.06%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.21B3.19B5.40B6.02B5.10B4.95B5.06B
Total Liabilities1.33B722.79M865.64M1.01B1.22B984.79M901.67M
Total Equity1.87B2.45B4.53B5.01B3.87B3.95B4.14B
Cash1.81B1.60B2.56B2.72B1.86B1.72B1.37B

Cash Flow

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow534.15M644.12M788.25M508.56M119.44M274.19M415.42M
Capital Expenditure28.94M49.59M112.41M115.76M42.98M24.34M27.09M
Free Cash Flow505.21M594.54M675.84M392.80M76.46M249.85M388.33M
Dividends Paid31.79K800.00M-211.44M163.99M75.25M127.69M
FCF to OCF94.58%92.30%85.74%77.24%64.02%91.12%93.48%
Dividend Paid to FCF0.01%134.56%-53.83%214.46%30.12%32.88%

Earnings

Report DateSep 30, 2021Mar 30, 2022Apr 29, 2022Aug 23, 2022Oct 28, 2022Mar 29, 2023Apr 27, 2023
EPS Estimate-------
EPS Actual0.310.490.240.750.110.260.24
Surprise-------
Timing-After-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap8.72B
Enterprise Value7.33B
Trailing P/E33.52
Forward P/E0.00
Price / Sales5.86
Price / Book2.09
EPS0.65
Book Value10.56
Revenue (TTM)1.49B
Gross Profit (TTM)928.38M
EBITDA309.62M
Profit Margin17.42%
Operating Margin23.67%
Return on Equity6.30%
Return on Assets3.24%
Shares Outstanding400.00M
Shares Float70.50M
Beta0.17
Dividend Yield1.51%
Dividend Rate0.33
Payout Ratio52.31%

Dividends

20262×
0.09Oct 13, 20260.24Jun 26, 2026
20252×
0.10Oct 21, 20250.17Jun 12, 2025
20243×
0.05Dec 12, 20240.07Oct 25, 20240.12Jul 5, 2024
20231×
0.41Jun 5, 2023
20221×
0.52May 26, 2022